Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8242160
Inhibitors of ubiquitin E1
granted patentUS 8242080
Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface
granted patentUS 8242112
Heterocyclic aspartyl protease inhibitors
granted patentUS 8242170
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce
granted patentUS 8236832
Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
granted patentUS 8236835
Heterocyclic inhibitors of stearoyl-CoA desaturase
granted patentUS 8236807
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted patentUS 8232406
c-MET protein kinase inhibitors
granted patentUS 8227516
Compounds as histone deacetylase inhibitors
granted patentUS 8222203
Macrocyclic oximyl hepatitis C serine protease inhibitors
granted patentUS 8222215
Methods for the use of inhibitors of antigen presentation by MHC class II molecules
granted patentUS 8221737
Hepatitis C virus inhibitors
granted patentUS 8222411
Dipeptidyl peptidase inhibitors
granted patentUS 8222293
Treating learning deficits with inhibitors of Hmg CoA reductase
granted patentUS 8222288
Small molecule inhibitors of MDM2 and the uses thereof
granted patentUS 8217056
Triazolothiadiazole inhibitor of c-Met protein kinase
granted patentUS 8217048
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 8211884
Diacylglycerol acyltransferase inhibitors
granted patentUS 8211914
Inhibitors of diacylglycerol acyltransferase
granted patentUS 8211891
Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
granted patentUS 8207142
Inhibitor of DNA methylation
granted patentUS 8202889
Inhibitors of bacterial IMPDH
granted patentUS 8202861
Compositions useful as inhibitors of voltage-gated sodium channels
granted patentUS 8202990
Polo-like kinase inhibitors
granted